Scott Scarneo
Affiliations: | 2018- | Pharmacology | Duke University, Durham, NC |
Google:
"Scott Scarneo"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Timothy Arthur James Haystead | grad student | 2018- | Duke | |
| Derek C Molliver | grad student | 2015-2017 | University of New England (Neurotree) | |
| (MS Biology Thesis: Co-mentored with Dr. Kat Hanlon) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Freeze R, Hughes P, Haystead T, et al. (2024) Transforming Growth Factor-β-Activated Kinase 1 (TAK1) Alleviates Inflammatory Joint Pain in Osteoarthritis and Gouty Arthritis Preclinical Models. Journal of Pain Research. 17: 2287-2298 |
| Damhofer H, Tatar T, Southgate B, et al. (2024) TAK1 inhibition leads to RIPK1-dependent apoptosis in immune-activated cancers. Cell Death & Disease. 15: 273 |
| Haystead T, Lee E, Cho K, et al. (2023) Investigation of SARS-CoV-2 individual proteins reveals the in vitro and in vivo immunogenicity of membrane protein. Scientific Reports. 13: 22873 |
| Freeze R, Yang KW, Haystead T, et al. (2023) Delineation of the distinct inflammatory signaling roles of TAK1 and JAK1/3 in the CIA model of rheumatoid arthritis. Pharmacology Research & Perspectives. 11: e01124 |
| Bale S, Verma P, Yalavarthi B, et al. (2023) Pharmacological inhibition of TAK1 prevents and induces regression of experimental organ fibrosis. Jci Insight |
| Scarneo S, Zhang X, Wang Y, et al. (2023) Transforming growth factor-β-activated kinase 1 (TAK1) mediates chronic pain and cytokine production in mouse models of inflammatory, neuropathic, and primary pain. The Journal of Pain |
| Scarneo SA, Smith AP, Favret J, et al. (2022) Expression of membrane Hsp90 is a molecular signature of T cell activation. Scientific Reports. 12: 18091 |
| Scarneo S, Hughes P, Freeze R, et al. (2022) Development and Efficacy of an Orally Bioavailable Selective TAK1 Inhibitor for the Treatment of Inflammatory Arthritis. Acs Chemical Biology |
| Wang Y, Scarneo SA, Kim SH, et al. (2021) Expression of ectopic heat shock protein 90 in male and female primary afferent nociceptors regulates inflammatory pain. Pain |
| Totzke J, Scarneo SA, Yang KW, et al. (2020) TAK1: a potent tumour necrosis factor inhibitor for the treatment of inflammatory diseases. Open Biology. 10: 200099 |